Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC (Trybeca-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03665441
Recruitment Status : Active, not recruiting
First Posted : September 11, 2018
Last Update Posted : February 15, 2021
Sponsor:
Information provided by (Responsible Party):
ERYtech Pharma

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 2021
Estimated Study Completion Date : October 2021